Company Neurobiological Technologies, Inc. Other OTC
Equities
NTII
US64124W3043
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Investigational Drugs
nan
%
| 26 | 100.0 % | 0 | nan % | -100.00% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 26 | 100.0 % | 0 | nan % | -100.00% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,019,805 | 27,019,805 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 2,332,000 | 0 | 1,838,000 ( 78.82 %) |
Company contact information
Neurobiological Technologies, Inc.
2000 Powell Street Suite 800
94608, Emeryville
+
Sector
1st Jan change | Capi. | |
---|---|---|
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+6.19% | 16TCr |